|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.520 EUR | -.--% |
|
-.--% | - |
| 20/04 | Exprivia SpA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 09/06/25 | Exprivia SpA Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 176M | 176M | 195M | 209M | 327M | |||||
Other Revenues, Total | 1.67M | 2.27M | 2.46M | 2.69M | 8.07M | |||||
Total Revenues | 178M | 178M | 197M | 212M | 335M | |||||
Cost of Goods Sold, Total | 154M | 155M | 174M | 185M | 300M | |||||
Gross Profit | 24.46M | 23.06M | 23.84M | 26.28M | 34.79M | |||||
Selling General & Admin Expenses, Total | 282K | 293K | 456K | 600K | - | |||||
Depreciation & Amortization - (IS) | 6.43M | 5.92M | 5.84M | 6.34M | 9.65M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | - | |||||
Other Operating Expenses | -283K | -2.33M | -3.57M | -3.1M | 1.8M | |||||
Other Operating Expenses, Total | 6.43M | 3.88M | 2.73M | 3.84M | 11.45M | |||||
Operating Income | 18.03M | 19.18M | 21.11M | 22.44M | 23.34M | |||||
Interest Expense, Total | -2.55M | -2.34M | -2.85M | -4.82M | -1.73M | |||||
Interest And Investment Income | 204K | 184K | 152K | 134K | - | |||||
Net Interest Expenses | -2.35M | -2.16M | -2.7M | -4.68M | -1.73M | |||||
Income (Loss) On Equity Invest. | 53K | -24K | - | - | - | |||||
Currency Exchange Gains (Loss) | 99K | 68K | -83K | -14K | - | |||||
Other Non Operating Income (Expenses) | -768K | -432K | -255K | 740K | - | |||||
EBT, Excl. Unusual Items | 15.07M | 16.64M | 18.07M | 18.49M | 21.61M | |||||
Gain (Loss) On Sale Of Assets | 102K | - | - | - | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | -15K | -60K | 39K | - | - | |||||
EBT, Incl. Unusual Items | 15.16M | 16.58M | 18.11M | 18.49M | 21.61M | |||||
Income Tax Expense | 5.02M | 5.04M | 4.96M | 5.15M | 6.39M | |||||
Earnings From Continuing Operations | 10.14M | 11.53M | 13.16M | 13.34M | 15.22M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 10.14M | 11.53M | 13.16M | 13.34M | 15.22M | |||||
Minority Interest | 32K | 1K | -16K | -48K | -399K | |||||
Net Income - (IS) | 10.17M | 11.53M | 13.14M | 13.29M | 14.82M | |||||
Net Income to Common Incl Extra Items | 10.17M | 11.53M | 13.14M | 13.29M | 14.82M | |||||
Net Income to Common Excl. Extra Items | 10.17M | 11.53M | 13.14M | 13.29M | 14.82M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.21 | 0.23 | 0.27 | - | - | |||||
Basic EPS - Continuing Operations | 0.21 | 0.23 | 0.27 | - | - | |||||
Basic Weighted Average Shares Outstanding | 47.34M | 50.36M | 47.82M | - | - | |||||
Net EPS - Diluted | 0.21 | 0.23 | 0.27 | - | - | |||||
Diluted EPS - Continuing Operations | 0.21 | 0.23 | 0.27 | - | - | |||||
Diluted Weighted Average Shares Outstanding | 47.34M | 50.36M | 47.82M | - | - | |||||
Normalized Basic EPS | 0.2 | 0.21 | 0.24 | - | - | |||||
Normalized Diluted EPS | 0.2 | 0.21 | 0.24 | - | - | |||||
Dividend Per Share | 0.05 | - | - | - | - | |||||
Payout Ratio | - | 19.58 | - | 21.16 | - | |||||
Supplemental Items | ||||||||||
EBITDA | 20.55M | 21.07M | 22.72M | 25.06M | 31.15M | |||||
EBITA | 18.76M | 19.77M | 21.58M | 22.92M | 23.34M | |||||
EBIT | 18.03M | 19.18M | 21.11M | 22.44M | 23.34M | |||||
EBITDAR | 20.83M | 21.37M | 23.18M | 25.66M | - | |||||
Total Revenues (As Reported) | 182M | 184M | 203M | 217M | 335M | |||||
Effective Tax Rate - (Ratio) | 33.1 | 30.42 | 27.36 | 27.85 | 29.58 | |||||
Current Domestic Taxes | 4.92M | 4.86M | 4.74M | 5.2M | - | |||||
Current Foreign Taxes | 35K | 65K | 46K | 50K | - | |||||
Total Current Taxes | 4.95M | 4.92M | 4.78M | 5.25M | - | |||||
Total Deferred Taxes | 234K | 139K | 191K | -21K | - | |||||
Normalized Net Income | 9.45M | 10.4M | 11.28M | 11.51M | 13.11M | |||||
Interest on Long-Term Debt | 175K | 176K | 176K | 175K | - | |||||
Non-Cash Pension Expense | 29K | 75K | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 5M | 1.2M | - | - | - | |||||
Net Rental Expense, Total | 282K | 293K | 456K | 600K | - | |||||
Imputed Operating Lease Interest Expense | 92.89K | 120K | 266K | 391K | - | |||||
Imputed Operating Lease Depreciation | 189K | 173K | 190K | 209K | - |
- Stock Market
- Stocks
- XPR Stock
- Financials EXPRIVIA
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















